Objectives to investigate ethnic differences in susceptibility to bradycardias in south asian and white european patients in the UK by determining rates of permanent pacemaker (PPM) implantation for sinus node dysfunction (snD) and atrioventricular block (aVB) in each ethnic group. Methods We carried out a retrospective cohort study into new PPM implantation during the period from 1
InTrOduCTIOn
Ethnic differences exist with respect to several cardiovascular diseases. For example, compared with Caucasians, people of South Asian ethnicity (India, Pakistan, Bangladesh, Sri Lanka) have increased incidence of coronary artery and cerebrovascular disease. [1] [2] [3] [4] [5] [6] [7] People of Afro-Caribbean/ African ethnicity in the UK have higher incidence of cerebrovascular, peripheral vascular and chronic kidney diseases, with lower rates of coronary artery disease, 3 4 while in North America, African-Americans have higher rates of cardiovascular disease compared with people of white ethnic background. 8 People of East Asian ethnic origin (China, Japan, Korea, Taiwan) have lower coronary artery disease, and higher cerebrovascular disease, rates. 8 9 Possible contributory factors to these ethnic variations in cardiovascular diseases include differences in profiles of cardiovascular risk factors 1 5 10 or socioeconomic conditions between ethnic groups [11] [12] [13] and differences in genetic susceptibility. 7 12 13 Bradycardias due to either sinus node disease (SND) or atrioventricular block (AVB) are an important cause of age-related cardiovascular morbidity. Presentation is typically with symptoms of dizziness, syncope or effort intolerance and either an abnormal resting ECG or rhythm monitoring can help to establish the diagnosis. While permanent pacemaker (PPM) implantation for all degrees of heart block may have symptomatic benefit, implantation in the context of Mobitz II, other higher degree AVB and third-degree heart block, has survival benefit. 14 15 On this background, European 14 and American 15 guidelines indicate that PPM devices should be implanted for lower degree AVB and SND only if symptomatic. On this basis, the number of new PPM implants should equate closely to the incidence of clinically significant SND and AVB. Few studies have explored whether there are ethnic differences in the risk of bradycardias. Recent data derived from two combined large, prospective cohort studies in the USA suggested ethnicity as a risk factor of SND with a lower risk in African-Americans compared with Caucasians. 16 PPM implantation rates following admission with complete heart block have also been reported to be lower in African-Americans compared with Caucasians, differences which were only partly explained by ethnic variation in access to health insurance cover. 17 Whether other ethnic groups have different risk profiles for SND or AVB compared with Caucasians remains unknown.
Individuals of South Asian ethnic origin make up the largest minority ethnic group in the UK, constituting approximately 4.9% of the total population. 18 In the county of Leicestershire, individuals of South Asian ethnicity constitute approximately 15% of the population. We have reported higher incidence rates of coronary artery disease 19 and heart failure 20 21 in the Leicestershire South Asian population compared with Caucasian patients, but similar 19 20 or better 21 case fatality. In this study, we aimed to use this enriched population with a high density of individuals of South Asian ethnicity to determine whether risk of bradycardias differ between South Asians and Caucasians by comparing PPM implantation rates in these two ethnic groups. To evaluate whether any differences observed were site-specific, we compared the indication (SND or AVB) by ethnic group.
MeThOds study design and population
We carried out a retrospective cohort study into cumulative PPM implantation rates at the University Hospitals of Leicester (UHL) between 1 May 2006 and 31 March 2014. The population at risk (the exposed population) was the population of Leicestershire. Data regarding the population at risk were obtained from the UK National Census of 2011, obtained via the Office for National Statistics. The 2011 Census was carried out at the midpoint of our study period and was thus likely to provide an accurate assessment of the size of the population and the ethnicity profile as this information is compulsorily collected as part of the Census. There was no large-scale migration of individuals into or out of the county during this period.
The study population constituted patients of Caucasian or South Asian ethnicity undergoing a PPM implantation at UHL, the primary provider of tertiary cardiology services to the people of Leicestershire. Ethnicity is routinely recorded locally for all procedures. Given small numbers of patients, and of PPM implantations, in other ethnic groups (Afro-Caribbean, other Africans, East Asians, Arabs and others), these were not considered in this analysis. We excluded patients with previous PPM implantation who attended for a generator change or lead repositioning or replacement. Patients with PPM who attended for device upgrades were also excluded as were those whose indication for PPM implantation was AV node ablation for refractory atrial arrhythmias. Only patients undergoing new PPM implantation for bradycardia were retained for the study. The UK total population from the 2011 Census was used as the population for direct standardisation.
Case ascertainment was achieved through the department of cardiology database which is fully complete, up to date and regularly audited. For each PPM implanted, the indication of SND or AVB was recorded, based on the indication recorded by the implanting physician. Our institution is the only National Health Service (NHS) healthcare facility in the county of Leicestershire at which PPM implantation takes place. This study was conducted as part of a clinical audit and therefore did not require ethics committee approval.
statistical analysis
Crude and age-specific cumulative PPM implantation rates per 1000 population were calculated for Caucasians and South Asians. Each patient was categorised in to one of four age groups: <25 years, 25-49 years, 50-74 years and ≥75 years. Attempts to categorise into smaller age bands were hampered by small numbers or the absence of implantation events in some age bands. In calculating the incidence, the numerator consisted of PPM first implants for each ethnic group, in total and by age group, while the denominator was the respective population from the 2011 Census. In view of the differences in age structure of the Caucasian and South Asian populations (Caucasians were on average older), PPM implantation rates were directly standardised using the UK general population from the 2011 Census. Age-specific crude PPM implantation rates for each ethnic group were applied within each age group (<25 years, 25-49 years, 50-74 years and ≥75 years) of the total UK population to obtain the age-specific expected event rates. The total number of expected, age-standardised events for each ethnic group was obtained by summing the age-specific events. We then calculated the age-adjusted incidence per 1000 population. Crude and age-standardised risk ratios (RRs) of PPM implantation for Caucasians compared with South Asians were calculated. Subgroup analyses for SND and AVB were also carried out. Analysis were performed using STATA V.11.
resulTs

Patient characteristics
In the 2011 Census, the Leicestershire population of 980 328 contained 761 403 (77.7%) individuals of Caucasian, 155 500 (15.8%) of South Asian and 63 425 (6.5%) of other ethnicity, respectively. During the study period, a total of 4883 patients received a first PPM for bradycardia at UHL. After exclusion of individuals from other minority ethnic groups (n=37), a total of 4846 patients with first implants were retained in the analysis, of which 4679 (96.55%) were Caucasians and 167 (3.45%) were South Asians (figure 1).
The demographic characteristics of patients who underwent PPM implantation, stratified by Caucasian/South Asian ethnicity 
Arrhythmias and sudden death
are shown in table 1. Caucasians were older and had a higher rate of atrial arrhythmias compared with South Asians. There were no significant differences overall in the main presenting symptoms and indications of PPM implantation between Caucasians and South Asians. However, South Asians were more likely than Caucasians to require pacemaker implantation in the context of an urgent presentation (table 1).
Cumulative incidence of PPM implantation by ethnicity, age and indication
The cumulative PPM implantation incidence for the total population during the study period was 4.98/1000 inhabitants. The incidence of PPM implantation for SND was 1.74/1000 inhabitants, AVB 2.83/1000 inhabitants and other indications 0.38/1000 inhabitants. These indications were not mutually exclusive.
Cumulative total PPM implantation incidence as well as those for the two main indications (SND and AVB) stratified by ethnicity and age groups are shown in table 2. In both Caucasians and South Asians, there were proportionately more implants for AVB than for SND, and rates of implantation increased dramatically after the age of 75 years. The unadjusted cumulative total PPM implantation rate in Caucasians (6.15/1000 population) was higher than in South Asians (1.07/1000), as were the incidence rates individually for AVB and SND (table 2) .
Because of the differences in the age structure of the Caucasian and South Asian populations (table 2), with the South Asian being substantially younger, we computed age-specific and total incidence rates for a whole UK population based on 2011 Census data using the rates observed in the two ethnic groups (table 3) . This gave age-standardised cumulative total PPM implantation rates of 5.60/1000 in Caucasians and 2.03/1000 in South Asians. The age-standardised incidence rates of PPM implantation for SND was 1.97/1000 in Caucasians compared with 0.53/1000 in South Asians, while corresponding, age-standardised rates for AVB were 3.17/1000 and 1.30/1000, respectively (table 3) .
Incidence rrs
The crude and age-standardised RRs of PPM implantation in South Asians compared with Caucasians are shown in table 4. Comparing South Asians to Caucasians, the standardised RR was lower at 0.36 (95% CI 0.36 to 0.37), that is, the standardised RR was higher for Caucasians at 2.70 (95% CI 2.68 to 2.71) compared with South Asians. Similar patterns were evident for PPM implantation for the indications of SND and AVB. In view of small numbers of events in patients in younger age categories, by way of sensitivity analysis, we calculated RR for patients aged ≥50 years of age. As can be seen in table 4, the age-standardised RR for PPM implantation was lower in South Asian patients for all indications, for SND and for AVB (0.38, 0.28 and 0.43, respectively, all P<0.0001).
dIsCussIOn
To the best of our knowledge, this is the first study to report differences in PPM implantation rates between Caucasians and South Asians. We observed an age-standardised first PPM implantation rate which was 2.7 times higher in Caucasian, compared with South Asian patients. This difference was apparent in implantation rates for both SND and AVB. As rates of PPM implantation are likely to be good surrogate for rates of clinically significant bradycardias, our data suggest that these conditions are much less common in South Asian patients in the UK, compared with the Caucasian population.
Individuals of South Asian origin constitute the single largest ethnic minority group in the UK, approximately 5% of the population. 18 In Leicestershire, South Asians constitute a much higher proportion of the population, 15.8% based on 2011 Census figures. In this context, the Leicestershire population is one in which ethnic differences in the epidemiology of individual disease states can be assessed with greater robustness than is possible in other areas. In this setting, our data indicating lower rates of PPM implantation in South Asian patients are likely to be reliable.
It has been reported that African-American men are less likely to be hospitalised for SND than white men. 22 A recent publication using combined data from two large prospective cohort studies in the USA suggested ethnic differences in the risk of sick sinus syndrome, with African-Americans having a 41% relative risk reduction compared with whites. 16 On this background, our observations support the notion of higher risk of cardiac bradycardias in Caucasians compared with other ethnic groups. There are a number of possible explanations for our observations. First, ascertainment bias, leading to underdiagnosis of cases of bradycardia in South Asian patients, either through poor access to, or underuse of, health services. Factors contributing to poor health access in ethnic minorities include linguistic barriers, level of literacy and cultural beliefs. 23 Data from the USA suggest socioeconomic status can contribute, to some extent, to differences in rates of PPM implantation in African-Americans and other ethnic minority groups compared with Caucasians. 24 Some reports have suggested underutilisation of healthcare services by people of lower socioeconomic class and the elderly in a UK setting 25 while others have not identified such an association. 26 We did not have access to details of socioeconomic status in the patients in our population. However, in the UK access to healthcare services is equitable, and healthseeking behaviours similar, in South Asians compared with Caucasians. 25 26 Indeed we have reported previously that South Asian patients with heart failure appear to access hospital services at an earlier stage of disease 21 and more frequently 20 than white patients in our population. It may be argued that socioeconomic and cultural differences might influence differences in cardiovascular disease risk between ethnic groups. Cardiovascular disease incidence rates are higher in South Asians in our locality compared with whites. 19 Further, cardiovascular disease risk factors are more prevalent in South Asians compared with white patients, with the exception of smoking. [19] [20] [21] It is unlikely that higher prevalence of cardiovascular disease risk factors together with equity of healthcare access would result in lower rates of bradycardia and PPM implantation observed here.
Second, there could be a problem of undertreatment or differential implantation of PPM, by clinicians influenced by the ethnic origin of the patient. This is unlikely, with studies utilising data from UK national registries indicating equitable provision of medical treatment and procedures for cardiovascular diseases for South Asians and white Europeans in the UK. 5 24 Third, as with other cardiovascular diseases, biological differences may underpin the variation among ethnic groups in terms of the propensity to SND and AVB. Specifically, recent genomewide association studies have identified genetic variants that are associated with risk of sick sinus syndrome 27 and parameters of AV cardiac conduction. 28 Further, some reports have suggested ethnic differences in single-nucleotide polymorphisms associated with cardiac QRS duration and P-R interval. 29 While we are not aware of demonstration of such differences specifically between South Asian and white European populations, it is possible that the presence of ethnic-specific variants contribute to the relative protection of South Asians from bradycardias. Interestingly, the incidence and prevalence of atrial fibrillation (AF) has also been reported to be higher in Caucasians when compared with other ethnic groups, even when ascertainment bias has been overcome, suggesting lower susceptibility to AF in non-white ethnic groups. 30 Indeed, we observed lower AF prevalence in South Asians in this report and previously in patients hospitalised with heart failure. 21 Whether the same mechanisms are responsible for the lower incidence of both bradycardias and AF in South Asians remains to be determined. Elucidation of these mechanisms may provide novel clues to the development of novel, non-device-based treatments for these disorders.
lIMITATIOns
Our data from a single centre may not be generalisable to South Asian patients in other areas of the UK. However, significant variance from our observations are unlikely, given the uniform provision of NHS provision across the country. We were unable to explore PPM implantation rates in ethnic minority groups other than South Asian, in view of very small numbers in our population. We are unable to discount ethnic differences in seeking and accessing healthcare, particularly among elderly South Asian individuals. However, as already noted, our local South Asian population appears to access healthcare in a similar way to other groups; moreover our data showed that the difference in implant rates was apparent across all age strata. With the use of Census data and age-standardisation statistical methods, it was not possible to correct for other possible confounding risk factors for bradycardia. However, as noted above, these covariates, with the exception of smoking, are more prevalent in South Asians, and cardiovascular disease rates are higher and we would have expected a higher rate of PPM implantation in South Asians, rather than the lower rates observed. With regard to case ascertainment, we acknowledge we may have failed to identify residents undergoing PPM implantation while outside of our area. Such numbers are likely to be very small and unlikely to have influenced our observations. Finally, although the incidence of PPM implantation is likely to reflect the incidence of clinically significant SND and Atrio-Ventricular Node Dysfunction (AVND), this is a surrogate for the true incidence of SND or AVND. Our study did not identify asymptomatic SND and lower degree AVN disease. Finally, we recognise residual confounding remains a possibility, as the main results of this study were only age standardised.
COnClusIOns
The rate of PPM implantation is lower in South Asians residing in the UK, compared with Caucasians. In the setting of equitable access to healthcare, our observations raise the possibility of lower, potentially genetic, susceptibility to bradycardias in South Asians. Future studies aimed at identifying any underlying driving genetic markers are warranted.
